To study the effect and mechanism of dimethyl fumarate [DMF] in adjuvant induced arthritis model in rats

Currently available disease modifying anti-rheumatoid drugs have limitations like dose-dependent toxicity and tolerance.Dimethyl fumarate has demonstrated anti-inflammatory and immunomodulatory properties in various animal models. Thus, thepresent study aimed to evaluate the effects and mechanism of DMF in a murine model of adjuvant-induced arthritis.A total of ۸۴ rats were divided into early treatment groups (n=۴۸) and late treatment groups (n=۳۶). There were ۸ subgroupsand ۶ subgroups (n=۶ in each group) in the early and late treatment groups, respectively. Experimental rheumatoid arthritis(RA) was induced in Wistar rats by injecting complete Freund's adjuvant (CFA) intradermally at the base of the tail. Antirheumatic effects were evaluated by arthritis and histopathological scoring of ankle joints. To evaluate anti-oxidant properties,GSH, catalase, SOD, and lipid peroxidation were measured. ESR, WBC count, TNF-α and IL-۶ levels were measured to evaluatethe immunomodulatory properties of DMF. DMF demonstrated anti-inflammatory effects by decreasing arthritis andhistopathological scores compared to the CFA control group, though the difference was not statistically significant. DMFexhibited immunomodulatory properties as decreases in TLC count, serum TNF-α, and plasma IL-۶ levels were observed. In allthe above-mentioned parameters, the best response was achieved with the early combination therapy of DMF ۳۰ mg/kg andmethotrexate [Mtx] ۰.۱ mg/kg. In the present study, DMF demonstrated antirheumatoid effects in a rat model of CFA-inducedarthritis. The best antirheumatoid effect was achieved with the early combination of DMF and Mtx.

کلیدواژه ها:

anti-inflammatory agents ، Antioxidants arthritis ، Dimethyl fumarate ، Freund's adjuvant ، Rheumatoid